{"issuance_frequency":"","notes_translated":{"fr":"Cette ligne directrice fournit aux promoteurs de produits à base de corticostéroïdes en inhalation (CSI) destinés au traitement de l`asthme des informations sur les exigences en matière de données cliniques comparatives afin d'établir l'innocuité et l'efficacité de leurs produits en vertu de l'article C.08 du Règlement sur les aliments et drogues.","en":"This guidance document provides sponsors of subsequent entry inhaled corticosteroid (ICS) products for the treatment of asthma with information on the comparative clinical data requirements in order to establish the safety and effectiveness of their products under Section C.08 of the Food and Drug Regulations."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"68e0af53-5c52-4e17-875a-d13583433fc3","metadata_created":"2021-06-01T17:11:50.361932","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2021-06-01T17:11:50.361939","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2021-06-01","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["document d'orientation","exigences en matière de données","sécurité et efficacité","corticostéroïdes en inhalation","asthme","traitement de l'asthme","exigences en matière de données cliniques"],"en":["guidance document","data requirements","safety and effectiveness","inhaled corticosteroid products","asthma","treatment of asthma","clinical data requirements"]},"relationships_as_object":[],"creator_user_id":"2dc5a12f-2a6f-4822-8514-165ea6bb05d9","title_translated":{"fr":"Avis : Ligne directrice - Exigences relatives à l’innocuité et l’efficacité pour des corticostéroïdes inhalés de commercialisation subséquente utilisés dans le traitement de l’asthme","en":"Notice: Guidance Document - Data Requirements for Safety and Effectiveness of Subsequent Entry Inhaled Corticosteroid Products Used for the Treatment of Asthma"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"68e0af53-5c52-4e17-875a-d13583433fc3","datastore_active":false,"id":"67596bc6-1671-43fa-ba69-d8ddc4fbe89e","character_set":"","state":"active","name_translated":{"fr":"Avis : Ligne directrice - Exigences relatives à l’innocuité et l’efficacité pour des corticostéroïdes inhalés de commercialisation subséquente utilisés dans le traitement de l’asthme","en":"Notice: Guidance Document - Data Requirements for Safety and Effectiveness of Subsequent Entry Inhaled Corticosteroid Products Used for the Treatment of Asthma"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Notice: Guidance Document - Data Requirements for Safety and Effectiveness of Subsequent Entry Inhaled Corticosteroid Products Used for the Treatment of Asthma","language":["en"],"created":"2021-06-01T17:11:50.452961","url":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/inhaled-corticosteroid-notice.html","last_modified":null,"position":0,"revision_id":"8f709337-1b52-4036-a4a8-41da93ff4d26","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"68e0af53-5c52-4e17-875a-d13583433fc3","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"66afe741-a1c8-4f58-ad55-0c0262571c40","related_relationship":"","name_translated":{"fr":"Avis : Ligne directrice - Exigences relatives à l’innocuité et l’efficacité pour des corticostéroïdes inhalés de commercialisation subséquente utilisés dans le traitement de l’asthme","en":"Notice: Guidance Document - Data Requirements for Safety and Effectiveness of Subsequent Entry Inhaled Corticosteroid Products Used for the Treatment of Asthma"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Notice: Guidance Document - Data Requirements for Safety and Effectiveness of Subsequent Entry Inhaled Corticosteroid Products Used for the Treatment of Asthma","language":["fr"],"created":"2021-06-01T17:11:50.452967","url":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/annonces/avis-corticosteroides-inhales.html","last_modified":null,"position":1,"revision_id":"8f709337-1b52-4036-a4a8-41da93ff4d26","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2018-10-31 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"68e0af53-5c52-4e17-875a-d13583433fc3","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"This guidance document provides sponsors of subsequent entry inhaled corticosteroid (ICS) products for the treatment of asthma with information on the comparative clinical data requirements in order to establish the safety and effectiveness of their products under Section C.08 of the Food and Drug Regulations.","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Notice: Guidance Document - Data Requirements for Safety and Effectiveness of Subsequent Entry Inhaled Corticosteroid Products Used for the Treatment of Asthma","revision_id":"8f709337-1b52-4036-a4a8-41da93ff4d26"}